EC Number   |
Inhibitors   |
Structure   |
|---|
  4.1.1.20 | N-[1-(3-chlorophenyl)-2-hydroxyethyl]-4-[5-chloro-2-[(propan-2-yl)amino]pyridin-4-yl]-1H-pyrrole-2-carboxamide |
0.04 mM, 47% inhibition, MIC for growth of Brucella melitensis 0.025 mM |
   |
  4.1.1.20 | N-(2-chloro-6-methylphenyl)-2-([6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino)-1,3-thiazole-5-carboxamide |
0.04 mM, 67% inhibition, MIC for growth of Brucella melitensis 0.1 mM |
   |
  4.1.1.20 | bis(azanido)platinum-cyclobutane-1,1-dicarboxylic acid |
0.04 mM, 65% inhibition, MIC for growth of Brucella melitensis 0.0002 mM |
   |
  4.1.1.20 | 4-imino-4-[2-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-3-methylbutanamide |
0.04 mM, 47.3% inhibition, MIC for growth of Brucella melitensis 0.05 mM |
   |
  4.1.1.20 | 2-(3-chloro-2-methylanilino)benzoic acid |
0.04 mM, 44% inhibition, MIC for growth of Brucella melitensis 0.025 mM |
   |
  4.1.1.20 | L,L-2,6-diaminoheptanedioate |
no detectable amounts of decarboxylation products |
   |
  4.1.1.20 | 2,3-Diaminopropionic acid |
- |
   |
  4.1.1.20 | diaminoheptanedioic acid |
analogs |
   |
  4.1.1.20 | D,L-alpha-aminoheptanedioate |
- |
   |
  4.1.1.20 | L-S-aminoethylcysteine |
- |
   |